HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Plaintiffs in a recently settled class-action data breach lawsuit against Irvine-based St. Joseph Health have started to receive their payouts.
Allergan PLC Chief Executive Brent Saunders said today that the drug maker will continue to seek “growth pharma” deals—including possible acquisitions that would complement its Irvine hub for Botox, ophthalmology and medical aesthetics—after the termination of its $160 billion mega-deal with Pfizer Inc.
Irvine-based Edwards Lifesciences Corp.’s shares shot up today after it reported positive results on a pair of less-invasive replacement heart valve clinical trials.
Newport Beach-based Alliant Insurance Services has acquired Andre-Romberg Insurance Agency in Spokane, Wash.
The Japanese Ministry of Health, Labor and Welfare has approved a glaucoma device made by Laguna Hills-based Glaukos Corp.
Longtime Orange County medical device executive James V. Mazzo has asked a judge for a stay in his federal insider trading case, according to court papers.
Newport Beach-based Alliance HealthCare Services Inc. said today that Fujian Thai Hot Investment Co. completed its purchase of a majority stake in the medical imaging company.
A University of California-Irvine scientific team has received $8 million from the U.S. Department of Defense to help develop a vaccine for Q fever, a highly infectious agent common among livestock.
Fountain Valley-based MemorialCare Health System will be cutting 194 jobs as part of its planned closure of the San Clemente location of its Saddleback Memorial Medical Center, according to a state filing.
Proove Helps Docs Manage Patients’ Discomfort
Brian Meshkin sought a way to help doctors make better decisions in the specialty of pain management, acting on the desire in 2009 when he created Irvine-based Proove Biosciences Inc.
San Clemente-based rubber products maker IRP Group Holdings recently agreed to combine with Garden Grove-based ProPlas Technologies on undisclosed terms.
Aliso Viejo-based Focal Therapeutics Inc. raised about $3.8 million in venture capital, according to a Securities and Exchange Commission filing.
Designed to Speed FDA OK for Certain Treatments
A cause dear to the hearts of medical device makers in Orange County and elsewhere—regulatory reform—is moving along in the U.S. Senate.
Irvine-based Edwards Lifesciences Corp. appointed Steven Loranger to its board of directors.
Aliso Viejo-based Focal Therapeutics Inc. has raised about $3.8 million in venture capital, according to a Securities and Exchange Commission filing.